{"id":15,"date":"2018-04-01T20:09:11","date_gmt":"2018-04-01T19:09:11","guid":{"rendered":"https:\/\/admin.innaxon.com\/?page_id=15"},"modified":"2025-08-20T12:16:32","modified_gmt":"2025-08-20T11:16:32","slug":"disclaimer","status":"publish","type":"page","link":"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/","title":{"rendered":"Disclaimer"},"content":{"rendered":"\n\n\t<h2><strong>Important Information<\/strong><\/h2>\n<p>DENDROPHILIN, NOVO-PYREXAL, MULTIVAX AND IAXO COMPOUNDS ARE NOT APPROVED FOR HUMAN, DIAGNOSTICS OR VETERINARY USE. USE OF THIS PRODUCT FOR HUMAN OR ANIMAL TESTING IS EXTREMELY HAZARDOUS AND MAY RESULT IN DISEASE, SEVERE INJURY, OR DEATH.<\/p>\n<p>The Innaxon\u00a0website has been created solely for information purposes.\u00a0 It is not intended to be used for advice or recommendation in any field including medicinal and financial, and should not be relied upon for such purposes.<\/p>\n<p>The content of the site is provided on an &#8220;as is&#8221; basis and\u00a0Innaxon\u00a0makes no representations or warranties in respect of it.<\/p>\n<p>Use of the website will be regarded by Innaxon\u00a0as an acceptance by the user of the risk of receiving incomplete, inaccurate or inappropriate information. The user accesses this website and uses its contents and links to other websites at his risk.<\/p>\n<p>Innaxon\u00a0accepts no liability for damages or injury of any kind whatsoever that may arise directly or indirectly there from, including damages resulting from computer viruses.The content of this website is protected by copyright laws and is the property of Innaxon.<\/p>\n<p>Users are prohibited from using it for commercial purposes without first obtaining the written consent of Innaxon. Use of the\u00a0Innaxon\u00a0website shall be governed by and interpreted in accordance with the laws of England and any communications from users in respect of it shall be on a non-confidential basis and may be used by Innaxon\u00a0for any purposes whatsoever.<\/p>\n<h3><strong><br \/>Research Use Only, 3rd Party Patents and Patent Applications<\/strong><\/h3>\n<p>Products currently covered by valid patents are offered for R&amp;D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Section 68B of the Patents Act of 1953 in New Zealand; (vi) such related legislation and\/or case law as may be or become applicable in the aforementioned countries; and (vii) such similar laws and rules as may apply in various other countries. In the European Union, equivalent exemptions are allowed under the terms of EC Directives 2001\/82\/EC (as amended by Directive 2004\/28\/EC) and 2001\/83\/EC (as amended by Directives 2002\/98\/EC, 2003\/63\/EC, 2004\/24\/EC and 2004\/27\/EC). Any patent infringement issue and resulting liability is solely at buyer&#8217;s risk.<\/p>\n<h3><strong><br \/>Copyright<\/strong><\/h3>\n<p>All content contained in this website is the property of Innaxon and may be used only with the expressed written permission of Innaxon. Copyright \u00a9 2010-2025 Innaxon. All rights reserved.<\/p>\n<h3><strong><br \/>Trademarks<\/strong><\/h3>\n<p>Innaxon<sup>\u00ae<\/sup>,\u00a0LPS Biosciences<sup>\u00ae<\/sup>, Dendrophilin<sup>\u00ae<\/sup>,\u00a0IMMUNOKINE<sup>\u00ae<\/sup>, MultiVAX<sup>\u00ae<\/sup>\u00a0and Novo-Pyrexal<sup>\u00ae<\/sup>\u00a0are registered trademarks of Innaxon.<\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Important Information DENDROPHILIN, NOVO-PYREXAL, MULTIVAX AND IAXO COMPOUNDS ARE NOT APPROVED FOR HUMAN, DIAGNOSTICS OR VETERINARY USE. USE OF THIS PRODUCT FOR HUMAN OR ANIMAL TESTING IS EXTREMELY HAZARDOUS AND MAY RESULT IN DISEASE, SEVERE INJURY, OR DEATH. The Innaxon\u00a0website has been created solely for information purposes.\u00a0 It is not<\/p>\n<p><a class=\"more-link\" href=\"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/\">Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-15","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Disclaimer - Innaxon Therapeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Disclaimer - Innaxon Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Important Information DENDROPHILIN, NOVO-PYREXAL, MULTIVAX AND IAXO COMPOUNDS ARE NOT APPROVED FOR HUMAN, DIAGNOSTICS OR VETERINARY USE. USE OF THIS PRODUCT FOR HUMAN OR ANIMAL TESTING IS EXTREMELY HAZARDOUS AND MAY RESULT IN DISEASE, SEVERE INJURY, OR DEATH. The Innaxon\u00a0website has been created solely for information purposes.\u00a0 It is notRead More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/\" \/>\n<meta property=\"og:site_name\" content=\"Innaxon Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-20T11:16:32+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/\",\"url\":\"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/\",\"name\":\"Disclaimer - Innaxon Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/admin.innaxon.com\/#website\"},\"datePublished\":\"2018-04-01T19:09:11+00:00\",\"dateModified\":\"2025-08-20T11:16:32+00:00\",\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/admin.innaxon.com\/#website\",\"url\":\"https:\/\/admin.innaxon.com\/\",\"name\":\"Innaxon Therapeutics\",\"description\":\"Targeting Innate Immunity For Therapeutic Benefit\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/admin.innaxon.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Disclaimer - Innaxon Therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/","og_locale":"en_GB","og_type":"article","og_title":"Disclaimer - Innaxon Therapeutics","og_description":"Important Information DENDROPHILIN, NOVO-PYREXAL, MULTIVAX AND IAXO COMPOUNDS ARE NOT APPROVED FOR HUMAN, DIAGNOSTICS OR VETERINARY USE. USE OF THIS PRODUCT FOR HUMAN OR ANIMAL TESTING IS EXTREMELY HAZARDOUS AND MAY RESULT IN DISEASE, SEVERE INJURY, OR DEATH. The Innaxon\u00a0website has been created solely for information purposes.\u00a0 It is notRead More","og_url":"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/","og_site_name":"Innaxon Therapeutics","article_modified_time":"2025-08-20T11:16:32+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/","url":"https:\/\/admin.innaxon.com\/index.php\/disclaimer\/","name":"Disclaimer - Innaxon Therapeutics","isPartOf":{"@id":"https:\/\/admin.innaxon.com\/#website"},"datePublished":"2018-04-01T19:09:11+00:00","dateModified":"2025-08-20T11:16:32+00:00","inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admin.innaxon.com\/index.php\/disclaimer\/"]}]},{"@type":"WebSite","@id":"https:\/\/admin.innaxon.com\/#website","url":"https:\/\/admin.innaxon.com\/","name":"Innaxon Therapeutics","description":"Targeting Innate Immunity For Therapeutic Benefit","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admin.innaxon.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/pages\/15","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/comments?post=15"}],"version-history":[{"count":5,"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/pages\/15\/revisions"}],"predecessor-version":[{"id":971,"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/pages\/15\/revisions\/971"}],"wp:attachment":[{"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/media?parent=15"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}